Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
XAIR
XAIR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
XAIR News
Beyond Air CEO Steve Lisi Resigns, Robert Goodman Appointed
4d ago
seekingalpha
Life Sciences Virtual Investor Forum Highlights Available On-Demand
Mar 13 2026
Globenewswire
Life Sciences Virtual Investor Forum Agenda Announced
Mar 10 2026
Globenewswire
Beyond Air Terminates Agreement with XTL Biopharmaceuticals
Mar 10 2026
seekingalpha
Beyond Air Terminates Proposed Transaction with XTL Biopharmaceuticals
Mar 10 2026
Newsfilter
Potential of High-Dose Inhaled Nitric Oxide for Antimicrobial Therapy
Feb 20 2026
Newsfilter
Beyond Air Reports Q3 Earnings with Revenue Beat
Feb 13 2026
seekingalpha
Beyond Air Reports 105% Revenue Growth in Q3
Feb 13 2026
Newsfilter
Beyond Air to Announce Q3 Earnings on February 13
Feb 12 2026
seekingalpha
XTL Biopharmaceuticals Acquires 85% of NeuroNOS for $1M and Up to $32.5M in Milestones
Jan 13 2026
stocktwits
Beyond Air (XAIR) Sells 85% of NeuroNOS for Up to $32.5 Million
Jan 13 2026
Benzinga
Dow Jones Falls Over 200 Points as Inflation Holds Steady
Jan 13 2026
Benzinga
JPMorgan Chase Reports Q4 Earnings Beat, Stock Volatility Observed
Jan 13 2026
Benzinga
XTL Biopharmaceuticals Acquires 85% of NeuroNOS to Target Autism Treatment Market
Jan 13 2026
Globenewswire
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Targeting Autism Therapeutics Market
Jan 13 2026
NASDAQ.COM
XTL Acquires 85% of NeuroNOS for $32.5 Million to Target Autism Treatment
Jan 13 2026
Globenewswire
Show More News
